Provided by Tiger Trade Technology Pte. Ltd.

HANSOH PHARMA

34.140
-1.160-3.29%
Volume:15.59M
Turnover:537.10M
Market Cap:207.02B
PE:31.37
High:34.660
Open:34.480
Low:33.640
Close:35.300
52wk High:43.587
52wk Low:27.658
Shares:6.06B
HK Float Shares:6.06B
Volume Ratio:1.98
T/O Rate:0.26%
Dividend:0.50
Dividend Rate:1.45%
EPS(LYR):1.088
ROE:19.40%
ROA:9.08%
PB:4.68
PE(LYR):31.37
PS:11.13

Loading ...

Movement Alert|Hansoh Pharmaceutical Falls 3.24% in Regular Trading, Pharmaceutical Sector Retreats After Prior Session Gains

Market Focus
·
Jul 07

Movement Alert|Hansoh Pharma Rises 3.74% in Regular Trading, HS-20136-2 Clinical Trial Approvals Continue to Drive Momentum Amid Pharma Sector Strength

Market Focus
·
Jul 06

Hansoh Pharmaceutical Group (SEHK:3692) Wins Trial Approval, Is It Fully Priced?

Simply Wall St.
·
Jul 05

Hansoh Pharma Keeps Share Base Steady at 6.06 Billion in June, Details HKD 4.68 Billion Convertible Bonds

Bulletin Express
·
Jul 03

Movement Alert|Hansoh Pharmaceutical Rises 4.41% in Regular Trading, HS-20136-2 Injection Receives Two Clinical Trial Approvals from NMPA

Market Focus
·
Jul 03

Hansoh Pharmaceutical Receives Dual NMPA Approvals for HS-20136-2 Injection Trials in Diabetes and Weight Management

Bulletin Express
·
Jul 02

Hansoh Pharma's HS-20136-2 Injection Receives NMPA Approval for Clinical Trials

Stock News
·
Jul 02

Hansoh Pharma Says China NMPA Clears Hs-20136-2 Injection for Clinical Trials in Type 2 Diabetes

Reuters
·
Jul 02

Hansoh Pharmaceutical - Clinical Trial Approvals for Hs-20136-2 Injection Issued- by Nmpa

THOMSON REUTERS
·
Jul 02

Hansoh Pharmaceutical Group Stock Rises 6.4% in Hong Kong

Dow Jones
·
Jul 02

Movement Alert|Hansoh Pharmaceutical Rises 6.01% in Regular Trading, Pemosatide Injection Approval Coupled with Pharma Sector Rally

Market Focus
·
Jul 02

Hansoh Pharmaceutical Group Stock Falls 2.3% in Hong Kong

Dow Jones
·
Jun 30

Movement Alert|Hansoh Pharmaceutical Falls 3.03% in Regular Trading, Pharmaceutical Sector Under Broad Selling Pressure

Market Focus
·
Jun 30

Hansoh Pharmaceutical Group Stock Rises 5.8% in Hong Kong

Dow Jones
·
Jun 29

Movement Alert|Hansoh Pharmaceutical Rises 4.88% in Regular Trading, Pharma Sector Rally Combines with Dense Pipeline Catalysts

Market Focus
·
Jun 29

Hansoh Pharma Shareholders Approved 2026 Share Scheme at AGM

Reuters
·
Jun 26

Hansoh Pharmaceutical Group Stock Slides 1.3% in Hong Kong

Dow Jones
·
Jun 24

Movement Alert|Hansoh Pharmaceutical Rises 3.18% in Regular Trading, Receives Inaugural Buy Rating from Guosheng Securities

Market Focus
·
Jun 24

Hansoh Pharmaceutical Group (SEHK:3692) Stock Could Be Below Fair Value After Hang Seng Index Inclusion

Simply Wall St.
·
Jun 21

Hansoh Pharma releases in vitro study data on HS-20094 dual-biased GLP-1/GIP agonist at ENDO 2026

Reuters
·
Jun 16